These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 173903)

  • 1. [Current studies on antilipemic agents].
    Kanaide H; Nakamura M
    Nihon Rinsho; 1975 Nov; 33(11):3205-10. PubMed ID: 173903
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of hypolipidemic drugs on serum lipoproteins.
    Carlson LA; Olsson AG
    Prog Biochem Pharmacol; 1979; 15():238-57. PubMed ID: 224397
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hyperlipoproteinemia].
    Meinders AE
    Ned Tijdschr Geneeskd; 1979 Mar; 123(15):617-28. PubMed ID: 219378
    [No Abstract]   [Full Text] [Related]  

  • 4. The primary hyperlipoproteinemias.
    Bybee DE; Hamilton RD
    J Ky Med Assoc; 1974 Dec; 72(12):658-62. PubMed ID: 4373515
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipid lowering effects on cardiovascular morbidity and mortality. Clinical evidence and therapeutic guidelines.
    Islami Y; Ribeiro LG
    Arq Bras Cardiol; 1988 Jul; 51(1):43-8. PubMed ID: 3073735
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of hyperlipidemia.
    Levy RI; Morganroth J; Rifkind BM
    N Engl J Med; 1974 Jun; 290(23):1295-301. PubMed ID: 4363888
    [No Abstract]   [Full Text] [Related]  

  • 7. Does hypolipidemic therapy prevent coronary heart disease?
    Rifkind BM; Levy RI
    Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303
    [No Abstract]   [Full Text] [Related]  

  • 8. [Present status of antilipemic agents].
    Takekoshi N; Murakami E
    Nihon Rinsho; 1980 Sep; 38(9):3138-48. PubMed ID: 7019504
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutics XIX. Lipid lowering agents.
    Frenk E; Walker AE; Edwards IR
    Br J Dermatol; 1972 Aug; 87(2):180-5. PubMed ID: 4560478
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperlipidemia: reducing the chances of cardiovascular disease.
    Nash DT
    Geriatrics; 1984 Jul; 39(7):99-100, 103-4,108-9 passim. PubMed ID: 6588017
    [No Abstract]   [Full Text] [Related]  

  • 11. Reducing cardiac deaths with hypolipidemic drugs.
    Naito HK
    Postgrad Med; 1987 Nov; 82(6):102-12. PubMed ID: 3313343
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hyperlipoproteinemias: experience of out-patient treatment of 112 patients (author's transl)].
    Arteaga A; Maiz A; Lathrop R
    Rev Med Chil; 1981 Oct; 109(10):945-51. PubMed ID: 7344018
    [No Abstract]   [Full Text] [Related]  

  • 13. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
    Orö L; Olsson AG; Rössner S; Carlson LA
    Postgrad Med J; 1975; 51(8):76-81. PubMed ID: 176639
    [No Abstract]   [Full Text] [Related]  

  • 14. [The importance of determining the type of hyperlipidemia for lipotropic therapy of atherosclerosis].
    Bavina MV; Perova NV; Lobova NM; Koropova GI
    Kardiologiia; 1973 Mar; 13(3):27-33. PubMed ID: 4717180
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical trials of cholestyramine alone and in combination with clofibrate in hypercholesterolemia].
    Carlson LA; Olsson AG; Orö L; Rössner S
    Lakartidningen; 1974 Sep; 71(36):3289-91. PubMed ID: 4605566
    [No Abstract]   [Full Text] [Related]  

  • 16. Bile acid metabolism in hyperlipoproteinaemia.
    Hellström K; Einarsson K
    Clin Gastroenterol; 1977 Jan; 6(1):103-28. PubMed ID: 196796
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clofibrate therapy--the status quo].
    Reuter W
    Z Gesamte Inn Med; 1982 Jan; 37(2):59-63. PubMed ID: 7080553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A
    Postgrad Med J; 1975; 51(8):suppl 66-71. PubMed ID: 215983
    [No Abstract]   [Full Text] [Related]  

  • 19. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
    Orö L; Olsson AG; Rössner S; Carlson LA
    Postgrad Med J; 1975; 51(8):suppl 76-81. PubMed ID: 215986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lipid-lowering drugs. Therapeutics and adverse effects].
    Vogelberg KH
    Med Klin; 1979 Aug; 74(32-33):1171-8. PubMed ID: 224293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.